Dergiler / Turkish Journal of Medical Sciences / 2019 / Cilt: 49 - Sayı: 4

The association between levels of inflammatory markers in autistic children compared to their unaffected siblings and unrelated healthy controls

Sayfa
1047–1053
Yayın Tarihi
2022-11-04
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

These results may lead to a betterunderstanding of the disorder’s pathophysiology, early testing, and diagnosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: Autism spectrum disorder (ASD) describes a range of neurodevelopmental disabilities that impair behavior andcommunication.
📊
Temel Bulgular & Veri:The aim of this studyis to identify a possible association between interleukin-6, -8, -9, and -10 and tumor necrosis factor alpha (TNF-α) in autism amongJordanian children by comparing the plasma levels of these cytokines in autistic children with those of their unaffected siblings andunrelated healthy controls.Materials and methods: In this study, 80 Jordanian children under the age of 12 with diagnosed autism were selected.
💡
Sonuç & Katkı:These results may lead to a betterunderstanding of the disorder’s pathophysiology, early testing, and diagnosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: Autism spectrum disorder (ASD) describes a range of neurodevelopmental disabilities that impair behavior andcommunication. Although it is relatively prevalent, the pathophysiology is still subject to speculation and debate. The aim of this studyis to identify a possible association between interleukin-6, -8, -9, and -10 and tumor necrosis factor alpha (TNF-α) in autism amongJordanian children by comparing the plasma levels of these cytokines in autistic children with those of their unaffected siblings andunrelated healthy controls.Materials and methods: In this study, 80 Jordanian children under the age of 12 with diagnosed autism were selected. For comparison,51 unaffected siblings and 86 unrelated healthy controls were also recruited. Venous blood was collected and interleukin levels in allthree groups were investigated.Results: Interleukin-6 was found to be significantly higher in the plasma of both autistic children and their siblings compared withthe unrelated healthy control group (P < 0.05). As for interleukin-8 and TNF-α, plasma levels were significantly higher exclusively inautistic children compared to their siblings and unaffected control subjects (P < 0.001, P < 0.001). There was no significant differencebetween plasma levels of the previously mentioned cytokines in the siblings and the unrelated control group. As for interleukin-9 andinterleukin-10, no significant differences were found between all three groups (P = 0.15, P = 0.35).Conclusion: We found that interleukin-8 and TNF-α were exclusively elevated in autistic Jordanian children, while interleukin-6was elevated in both autistic children and their siblings, potentially dismissing its significance. These results may lead to a betterunderstanding of the disorder’s pathophysiology, early testing, and diagnosis.

🔖

Bu Makaleye Atıf Yap

QWAIDER, Y. Z., ABDELHAMID, S. S., ALZGHOUL, L., ALDAHABI, M., YANIS, A. H., ALBDOUR, S. A. (2022). The association between levels of inflammatory markers in autistic children compared to their unaffected siblings and unrelated healthy controls. Turkish Journal of Medical Sciences, Cilt: 49 - Sayı: 4, 1047–1053. https://ajindex.com/articles/610014

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Hervas A. One autism, several autisms. Phenotypical variability in autism spectrum disorders. Revista de Neurología 2016; 62 (1): 9-14
  2. Baio J, Wiggins L, Christensen DL, Maenner MJ, Daniels J et al. Prevalence of autism spectrum disorder among children aged 8 years. Surveillance Summaries 2018; 67 (6): 1-23. doi: 10.15585/mmwr.ss6706a1 3. Chaaya M, Saab D, Maalouf FT, Boustany RM. Prevalence of autism spectrum disorder in nurseries in Lebanon: a cross sectional study. Journal of Autism and Developmental Disorders 2016; 46 (2): 514-522. doi: 10.1007/s10803-015- 2590-7 4. Gottfried C, Bambini-Junior V, Francis F, Riesgo R, Savino W. The impact of neuroimmune alterations in autism spectrum disorder. Frontiers in Psychiatry 2015; 6: 121. doi: 10.3389/ fpsyt.2015.00121 5. Atladóttir HO, Pedersen MG, Thorsen P, Mortensen PB, Delevran B et al. Association of family history of autoimmune diseases and autism spectrum disorders. Pediatrics 2009; 124 (2): 687-694. doi: 10.1542/peds.2008-2445 6. Sweeten TL, Posey DJ, McDougle CJ. High blood monocyte counts and neopterin levels in children with autistic disorder. American Journal of Psychiatry 2003; 160 (9): 1691-1693. doi: 10.1176/appi.ajp.160.9.1691 7. Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain, Behavior, and Immunity 2010; 24 (1): 64-71. doi: 10.1016/J.BBI.2009.08.001 8. Dantzer R. Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. European Journal of Pharmacology 2004; 500 (1-3): 399-411. doi: 10.1016/J.EJPHAR.2004.07.040 9. Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. Journal of Leukocyte Biology 2006; 80 (1): 1-15. doi: 10.1189/jlb.1205707 10. Meltzer A, Van de Water J. The role of the immune system in autism spectrum disorder. Neuropsychopharmacology 2017; 42 (1): 284-298. doi: 10.1038/npp.2016.158 11. Xu N, Li X, Zhong Y. Inflammatory cytokines: potential biomarkers of immunologic dysfunction in autism spectrum disorders. Mediators of Inflammation 2015; 2015: 1-10. doi: 10.1155/2015/531518 12. Ashwood P, Krakowiak P, Hertz-Picciotto I, Hansen R, Pessah I et al. Elevated plasma cytokines in autism spectrum disorders provide evidence of immune dysfunction and are associated with impaired behavioral outcome. Brain, Behavior, and Immunity 2011; 25 (1): 40-45. doi: 10.1016/J.BBI.2010.08.003 13. Pan HF, Leng